CEEMAST Dry Cow Intramammary Suspension

Pajjiż: Irlanda

Lingwa: Ingliż

Sors: HPRA (Health Products Regulatory Authority)

Ingredjent attiv:

Cefalexin; Dihydrostreptomycin

Disponibbli minn:

Cross Vetpharm Group Limited

Kodiċi ATC:

QJ51RD01

INN (Isem Internazzjonali):

Cefalexin; Dihydrostreptomycin

Dożaġġ:

500/500 mg/syringe

Għamla farmaċewtika:

Intramammary suspension

Tip ta 'preskrizzjoni:

POM: Prescription Only Medicine as defined in relevant national legislation

Grupp terapewtiku:

Cattle

Żona terapewtika:

cefalexin, combinations with other antibacterials

Indikazzjonijiet terapewtiċi:

Antibacterial

L-istatus ta 'awtorizzazzjoni:

Authorised

Data ta 'l-awtorizzazzjoni:

2008-02-15

Karatteristiċi tal-prodott

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
CEEMAST Dry Cow Intramammary Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Intramammary suspension.
10 ml intramammary syringe containing 9 g of a smooth pale pink or
pale yellow sterile product.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dry cows.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of sub clinical mastitis infection present at drying
off in cows and to assist in preventing new
infections occurring during the dry period.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active
ingredients.
Do not use in lactating cows.
Do not use within 40 days of the estimated calving date.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Each syringe contains:
Active Substances
Cefalexin
500 mg
Dihydrostreptomycin
(as Dihydrostreptomycin Sulphate)
500 mg
For a full list of excipients see section 6.1
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_4_
_/_
_0_
_8_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_4_
_1_
_0_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Not intended for use within 40 days of the estimated calving date.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
Operators should avoid contact with this preparation as occasional
skin allergy may
occur.
Penicillins a